BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31689349)

  • 1. Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN.
    Martinelli M; Giugliano FP; Strisciuglio C; Urbonas V; Serban DE; Banaszkiewicz A; Assa A; Hojsak I; Lerchova T; Navas-López VM; Romano C; Sladek M; Veres G; Aloi M; Kucinskiene R; Miele E
    Inflamm Bowel Dis; 2020 Aug; 26(9):1407-1414. PubMed ID: 31689349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: implications on public health policies.
    García-Serrano C; Mirada G; Marsal JR; Ortega M; Sol J; Solano R; Artigues EM; Estany P
    BMC Public Health; 2020 May; 20(1):713. PubMed ID: 32429900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization history of children with inflammatory bowel disease.
    Soon IS; deBruyn JC; Wrobel I
    Can J Gastroenterol; 2013 Apr; 27(4):213-6. PubMed ID: 23616959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
    Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
    Jones JL; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Benchimol EI
    Gastroenterology; 2021 Aug; 161(2):681-700. PubMed ID: 34334167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
    Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL
    Gastroenterology; 2021 Aug; 161(2):669-680.e0. PubMed ID: 33617891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
    Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
    Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease.
    Walsh AJ; Weltman M; Burger D; Vivekanandarajah S; Connor S; Howlett M; Radford-Smith G; Selby W; Veillard AS; Grimm MC; Travis SP; Lawrance IC
    J Crohns Colitis; 2013 Nov; 7(10):e449-56. PubMed ID: 23601754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel Disease.
    Caldera F; Misch EA; Saha S; Wald A; Zhang Y; Hubers J; Megna B; Ley D; Reichelderfer M; Hayney MS
    Dig Dis Sci; 2019 Jan; 64(1):189-195. PubMed ID: 30317494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.
    Marín AC; Gisbert JP; Chaparro M
    World J Gastroenterol; 2015 Oct; 21(40):11273-81. PubMed ID: 26527572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination coverage of children with inflammatory bowel disease after an awareness campaign on the risk of infection.
    Fleurier A; Pelatan C; Willot S; Ginies JL; Breton E; Bridoux L; Segura JF; Chaillou E; Jobert A; Darviot E; Cagnard B; Delaperriere N; Grimal I; Carre E; Wagner AC; Sylvestre E; Dabadie A
    Dig Liver Dis; 2015 Jun; 47(6):460-4. PubMed ID: 25770456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease.
    Crawford NW; Catto-Smith AG; Oliver MR; Cameron DJ; Buttery JP
    BMC Gastroenterol; 2011 Jul; 11():87. PubMed ID: 21798078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with vaccination among inflammatory bowel disease patients in Korea.
    Yun HS; Min YW; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH
    Korean J Gastroenterol; 2013 Apr; 61(4):203-8. PubMed ID: 23624734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis.
    Cleveland NK; Rodriquez D; Wichman A; Pan I; Melmed GY; Rubin DT
    Dig Dis Sci; 2016 Oct; 61(10):2972-2976. PubMed ID: 27557706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates in vaccination: recommendations for adult inflammatory bowel disease patients.
    Chaudrey K; Salvaggio M; Ahmed A; Mahmood S; Ali T
    World J Gastroenterol; 2015 Mar; 21(11):3184-96. PubMed ID: 25805924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination strategies in pediatric inflammatory bowel disease.
    Dipasquale V; Romano C
    Vaccine; 2017 Oct; 35(45):6070-6075. PubMed ID: 28967524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.
    Andrade P; Santos-Antunes J; Rodrigues S; Lopes S; Macedo G
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1591-5. PubMed ID: 25967740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy.
    Mow WS; Abreu-Martin MT; Papadakis KA; Pitchon HE; Targan SR; Vasiliauskas EA
    Clin Gastroenterol Hepatol; 2004 Apr; 2(4):309-13. PubMed ID: 15067625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
    Kurti Z; Lovasz BD; Gecse KB; Balint A; Farkas K; Morocza-Szabo A; Gyurcsanyi A; Kristof K; Vegh Z; Gonczi L; Kiss LS; Golovics PA; Lakatos L; Molnar T; Lakatos PL
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMMUNIZATION STATUS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Strasse KLA; Jamur CM; Marques J; Kim MSM; Petterle RR; Amarante HMBDS
    Arq Gastroenterol; 2019 Aug; 56(2):124-130. PubMed ID: 31460574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.